A prognostically relevant miRNA signature for epithelial ovarian cancer

Daniel W Cramer1, Kevin M Elias2

  • 1Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

The Lancet. Oncology
|July 13, 2016
PubMed
Abstract

No abstract available in PubMed .